Technology Senolytic Therapeutics To Eliminate Senescent Cells And Enhance Aging And Cancer Treatments Targeted approach to remove aging, disease-related, or chemotherapy/immunotherapy-induced senescent cells while sparing healthy cells The Unmet Need: Approaches to selectively eliminate senescent cells improving aging symptoms without damaging healthy…
News Innovation Fund Invests $575,000 in Biotech Companies The University of Chicago Innovation Fund announced plans to invest up to $575,000 into three biotechnology companies—ImmunArtes, Onchilles Pharma, and Oxalo Therapeutics. These latest investments bring the Innovation Fund’s total...
News RiMO Therapeutics Announces Enrollment of the First Patient in Phase 1 Study of RiMO-301 with Radiation in Advanced Tumors
Technology Rapid Selection Of High-Value Internalizing Binders For Targeted Therapeutics Lentiviral display platform engineered to directly select and enrich antibodies based on their ability to induce receptor-mediated endocytosis, thereby streamlining the discovery of highly internalizing candidates for targeted therapies The…
News NanoPattern Technologies, ReAx Biotechnologies Receive $150,000 Each to Commercialize Research The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has chosen two companies – NanoPattern Technologies and ReAx Biotechnologies – to invest in as part of the...
News Navigating Startup Success: Polsky Launches the ‘Compass,’ a New Deep Tech Accelerator Program The Polsky Center for Entrepreneurship and Innovation recently launched the Compass – a first-of-its-kind deep tech accelerator program for early-stage startups and technologies. “Backed by a 25-year history of launching...
News 21 Teams Tackling Innovations in Quantum, Healthcare, AI, and More Take First Steps Toward Commercialization Twenty-one teams from across the University of Chicago and local institutions participated in the Polsky Center I-Corps program this year – identifying and addressing real-world problems in seven weeks, work...
Technology SARS-CoV-2 Monoclonal Antibodies Against Spike and Internal Proteins for Therapeutics and Diagnostics As of February 2021, there have been over 107 million cases and over 2 million deaths caused worldwide by the novel virus SARS-CoV-2. Few vaccination and treatment approaches are currently…
Technology Mesenchymal Stem Cell And Exosome-Based Therapeutics For Restoring Ovarian Function In Premature Ovarian Insufficiency Therapeutic strategy using human mesenchymal stem cells or their exosomes to restore ovarian function and fertility in premature ovarian insufficiency by promoting cell growth, reducing cell death, and enhancing blood…
Technology Small Molecule Therapeutics For Inducing Trained Innate Immunity And Enhanced Anti-Tumor Responses Small molecule drugs developed to induce trained immunity in macrophage cells resulting in a heightened pro-inflammatory response without triggering a primary immune response The Unmet Need: Trained immunity induction that…
